Module Database Search
| MODULE DESCRIPTOR | |||
|---|---|---|---|
| Module Title | |||
| Clinical Therapeutics 3 | |||
| Reference | PL4002 | Version | 1 |
| Created | April 2022 | SCQF Level | SCQF 10 |
| Approved | June 2022 | SCQF Points | 30 |
| Amended | August 2021 | ECTS Points | 15 |
| Aims of Module | |||
|---|---|---|---|
| To integrate scientific principles and clinical skills to evidence-based therapeutics relating to specific body systems including the application of pharmacokinetic principles. | |||
| Learning Outcomes for Module | |
|---|---|
| On completion of this module, students are expected to be able to: | |
| 1 | Critically evaluate patient information to identify pharmacological and therapeutic issues in a range of common pathophysiological conditions. |
| 2 | Synthesise appropriate evidence based therapeutic strategies in relation to a range of diseases. |
| 3 | Justify effective drug and non-drug interventions for improving the health of patients and clients |
| 4 | Apply practical clinical skills (communication, consultation, data gathering from case notes, physical assessment) to improve health outcomes. |
| Indicative Module Content |
|---|
| Integration of the scientific principles and clinical skills required to develop evidence based therapeutic plans for individual patients in the context of specific disease states including: endocrine diseases; cardiovascular diseases; haematology; renal disease and clinical skills including communication, consultation, data gathering from case notes, physical assessment. |
| Module Delivery |
|---|
| Lectures, coursework sessions (that include individual problem solving exercises and group based problem-based learning, tutorial sessions) and directed study (that include computer packages, directed reading and self-assessment exercises). |
| Indicative Student Workload | Full Time | Part Time |
|---|---|---|
| Contact Hours | 50 | N/A |
| Non-Contact Hours | 250 | N/A |
| Placement/Work-Based Learning Experience [Notional] Hours | N/A | N/A |
| TOTAL | 300 | N/A |
| Actual Placement hours for professional, statutory or regulatory body |
| ASSESSMENT PLAN | |||||
|---|---|---|---|---|---|
| If a major/minor model is used and box is ticked, % weightings below are indicative only. | |||||
| Component 1 | |||||
| Type: | Coursework | Weighting: | 50% | Outcomes Assessed: | 1 |
| Description: | Assessment of case study presentation. | ||||
| Component 2 | |||||
| Type: | Practical Exam | Weighting: | 50% | Outcomes Assessed: | 2, 3, 4 |
| Description: | Cardiovascular risk assessment | ||||
| MODULE PERFORMANCE DESCRIPTOR | ||||||||
|---|---|---|---|---|---|---|---|---|
| Explanatory Text | ||||||||
| Component 1 (CW1) comprises 50% of the module grade. A minimum of a Grade D or better is required to pass this assessment. Component 2 (PE1) comprises 50% of the module grade. A minimum of a Grade D or better is required to pass this assessment. Overall Grade D or better is required to pass this module. Non-submission of either component will result in an NS grade for the module. | ||||||||
| Coursework: | ||||||||
| Practical Exam: | A | B | C | D | E | F | NS | |
| A | A | A | B | B | E | E | ||
| B | A | B | B | C | E | E | ||
| C | B | B | C | C | E | E | ||
| D | B | C | C | D | E | F | ||
| E | E | E | E | E | E | F | ||
| F | E | E | E | F | F | F | ||
| NS | Non-submission of work by published deadline or non-attendance for examination | |||||||
| Module Requirements | |
|---|---|
| Prerequisites for Module | Successful completion of MPharm Stage 2 or equiavalent. |
| Corequisites for module | None. |
| Precluded Modules | None. |
| INDICATIVE BIBLIOGRAPHY | |
|---|---|
| 1 | NEAL, M.J., 2015. Medical Pharmacology at a Glance. Eight edition. Oxford: Wiley-Blackwell. |
| 2 | RANG, H. P. RITTER, J.M., FLOWER, R.J. and HENDERSON, G., 2015. Rang and Dale's Pharmacology. Eight edition. London: Churchill Livingstone. |
| 3 | WALKER R., and WHITTLESEA C., 2019. Clinical Pharmacy and Therapeutics. Sixth edition. Edinburgh: Churchill Livingstone. |